ProPhase Labs, Inc.
PRPH
$0.05
$0.0120.05%
OTC PK
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -39.03% | -11.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -39.03% | -11.21% | |||
| Cost of Revenue | -42.09% | -46.62% | |||
| Gross Profit | -32.39% | 300.81% | |||
| SG&A Expenses | -53.59% | 28.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -52.64% | 15.28% | |||
| Operating Income | 54.51% | -20.19% | |||
| Income Before Tax | 50.37% | -14.64% | |||
| Income Tax Expenses | 320.90% | -296.18% | |||
| Earnings from Continuing Operations | 27.63% | -8.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 27.63% | -8.17% | |||
| EBIT | 54.51% | -20.19% | |||
| EBITDA | 65.50% | -27.83% | |||
| EPS Basic | -29.96% | 79.68% | |||
| Normalized Basic EPS | 28.14% | 75.88% | |||
| EPS Diluted | -29.96% | 79.68% | |||
| Normalized Diluted EPS | 28.14% | 75.88% | |||
| Average Basic Shares Outstanding | -44.31% | 432.42% | |||
| Average Diluted Shares Outstanding | -44.31% | 432.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||